Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The conclusion is that fat grafting is safe and effective but carries risks that need careful management.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Using neurohormones to control keratin can lead to new skin disease treatments.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Micropigmentation safely and effectively hides scalp hair loss and scars.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Finasteride effectively treats male hair loss, increasing length and thickness.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Tissue expansion is a useful method for reconstructive surgery with good results and room for further enhancement.

Hair loss doesn't affect COVID-19 severity.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.